Authors: MAASS N EIDTMANN H ARPS H JONAT W

Citation: N. Maass et al., PROGESTERONE ANTAGONIST ZK-98.299 (ONAPRISTONE) INHIBITS GROWTH OF THE ESTROGEN-RECEPTOR (ER) AND PROGESTERONE-RECEPTOR (PR) POSITIVE BREAST-CANCER CELL-LINE MCF-7, Tumordiagnostik & Therapie, 15(1), 1994, pp. 6-11

Authors: JONAT W EIDTMANN H FRIEDRICHS K

Citation: W. Jonat et al., PROGNOSTIC FACTORS IN BREAST-CANCER, Der Gynakologe, 27(1), 1994, pp. 37-44

Authors: WINTER K EIDTMANN H JONAT W

Citation: K. Winter et al., CYTOMETRIC-FLOW MEASURED S-PHASE FRACTION AND PLOIDY AS PROGNOSTIC FACTORS IN PRIMARY NODE-NEGATIVE BREAST-CANCER, Geburtshilfe und Frauenheilkunde, 54(5), 1994, pp. 291-294

Authors: MAASS H EIDTMANN H SCHREER I

Citation: H. Maass et al., TREATMENT OF CARCINOMA IN-SITU, Archives of gynecology and obstetrics, 254(1-4), 1993, pp. 750-755

Authors: EIDTMANN H LANGE C JONAT W MAASS H

Citation: H. Eidtmann et al., ADJUVANT SYSTEMIC THERAPY OF NODE-NEGATIV E MAMMARY CARCINOMAS - DO ESTABLISHED FACTORS HELP WITH THE CHOICE OF THERAPY, Archives of gynecology and obstetrics, 254(1-4), 1993, pp. 871-872

Authors: FRIEDRICHS K GLUBA S EIDTMANN H JONAT W

Citation: K. Friedrichs et al., OVEREXPRESSION OF P53 AND PROGNOSIS IN BREAST-CANCER, Cancer, 72(12), 1993, pp. 3641-3647